Story clusterResearch theme2 articles1 sources
Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
The exchange highlights unresolved methodological questions about how to analyze acute vestibular migraine treatment trials, which matter for how audiologists and vestibular specialists interpret future rimegepant evidence.
Evidence: 5Vestibular
PubMedJournal article · Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migrainePubMedJournal article · Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
PubMed